Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study

SUMMARY: To determine persistence with subcutaneous denosumab every 6 months in women being treated for osteoporosis, we conducted a single-arm prospective, observational study in the United States and Canada. Among 935 patients enrolled, 12-month persistence was 82 %, with 66 patients (7 %) reporti...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverman, S. L., Siris, E., Kendler, D. L., Belazi, D., Brown, J. P., Gold, D. T., Lewiecki, E. M., Papaioannou, A., Simonelli, C., Ferreira, I., Balasubramanian, A., Dakin, P., Ho, P., Siddhanti, S., Stolshek, B., Recknor, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286624/
https://www.ncbi.nlm.nih.gov/pubmed/25236877
http://dx.doi.org/10.1007/s00198-014-2871-6

Ejemplares similares

Ejemplares similares